Immunologists Prakash Nagarkatti and Mitzi Nagarkatti of the University of South Carolina explain what makes it different from previous variants, whether there will be another surge in the US and how best to protect yourself.
Mitzi Nagarkatti, PhD
Dr. Mitzi Nagarkatti is SmartState Endowed Chair of Center for Cancer Drug Discovery as well as Carolina Distinguished Professor and Chair of the Dept. of Pathology, Microbiology and Immunology at the School of Medicine (SOM), University of South Carolina (UofSC). In 2005, Dr. Nagarkatti moved from the Medical College of Virginia where she was a Professor in the Dept. of Microbiology and Immunology as well as directed the Immune Mechanisms Program of the National Cancer Institute (NCI)-designated Massey Cancer Center.